Chembio Diagnostics Stock Target Price and Analyst Consensus

CEMI -  USA Stock  

USD 0.64  0.01  1.59%

The current analyst and expert consensus on Chembio Diagnostics is Hold, with 0 strong sell and 0 strong buy opinions. The current projected Chembio Diagnostics target price consensus is 0.0 with 0 analyst opinions. The most common way Chembio Diagnostics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Chembio Diagnostics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Chembio Diagnostics. We encourage you to use your own analysis of Chembio Diagnostics to validate this buy or sell advice. Chembio Diagnostics buy-or-sell recommendation module provides average expert sentiment on the projected Chembio Diagnostics target price to derive its highest and lowest estimates based on projected price volatility of 0.0. Continue to Macroaxis Advice on Chembio Diagnostics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh
The current Gross Profit is estimated to decrease to about 13.3 M. The current Profit Margin is estimated to decrease to -0.73. Chembio Diagnostics Total Debt is most likely to increase significantly in the upcoming years. The last year's value of Total Debt was reported at 25.86 Million. The current Debt Current is estimated to increase to about 2.3 M, while Accumulated Other Comprehensive Income is projected to decrease to (608 K).

Chembio Diagnostics Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Chembio target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Chembio target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of OpinionsOne
Lowered Outlook0
Raized Outlook0
Hold
Most Chembio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Chembio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Chembio Diagnostics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Chembio Diagnostics Target Price Projection

Chembio Diagnostics' current and average target prices are 0.64 and 0.00, respectively. The current price of Chembio Diagnostics is the price at which Chembio Diagnostics is currently trading. On the other hand, Chembio Diagnostics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Chembio Diagnostics Market Quote on 24th of May 2022

Low Price0.64Odds
High Price0.64Odds

0.64

Target Price

Analyst Consensus On Chembio Diagnostics Target Price

Low Estimate0.0Odds
High Estimate0.0Odds
Number of AnalystsOne
Standard Deviation0.0

0.0

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Chembio Diagnostics and the information provided on this page.

Chembio Diagnostics Analyst Ratings

Chembio Diagnostics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Chembio Diagnostics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Chembio Diagnostics' financials, market performance, and future outlook by experienced professionals. Chembio Diagnostics' historical ratings below, therefore, can serve as a valuable tool for investors.

Average Consensus Estimates

About Chembio Diagnostics Target Price Projections

Chembio Diagnostics's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Chembio Diagnostics and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Chembio depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Chembio Diagnostics including analysis of its current option contracts.
Chembio Diagnostics' latest option contracts expiring on 2022-06-17 are carrying combined implied volatility of 43.59 with a put-to-call open interest ratio of 0.11 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-06-17. The current put volume is at 1, with calls trading at the volume of 7. This yields a 0.14 put-to-call volume ratio. The Chembio Diagnostics option chain provides detailed quote and price information for the current Chembio Diagnostics option contracts. It shows all of Chembio Diagnostics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Chembio Diagnostics' stock options are financial instruments that give investors the right to buy or sell shares of Chembio Diagnostics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Chembio stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Chembio Diagnostics' stock price goes up or down, the stock options follow.
Continue to Macroaxis Advice on Chembio Diagnostics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Chembio Current Options Market Mood

Chembio Diagnostics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Chembio Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Chembio Diagnostics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Chembio Diagnostics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Chembio Diagnostics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Chembio Diagnostics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Chembio Diagnostics is a key component of Chembio Diagnostics valuation and have some predictive power on the future returns of a Chembio Diagnostics.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Chembio Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Chembio Diagnostics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.030.6312.30
Details
Intrinsic
Valuation
LowReal ValueHigh
0.030.6012.27
Details
Naive
Forecast
LowNext ValueHigh
0.0157850.7912.46
Details
Earnings
Estimates (1)
LowProjected EPSHigh
-1.04-1.04-1.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Chembio Diagnostics. Your research has to be compared to or analyzed against Chembio Diagnostics' peers to derive any actionable benefits. When done correctly, Chembio Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Chembio Diagnostics.

Additional Chembio Diagnostics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Chembio Diagnostics is a key component of Chembio Diagnostics valuation and have some predictive power on the future returns of a Chembio Diagnostics.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Chembio Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Chembio Diagnostics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.030.6312.30
Details
Intrinsic
Valuation
LowReal ValueHigh
0.030.6012.27
Details
Naive
Forecast
LowNext ValueHigh
0.0157850.7912.46
Details
Earnings
Estimates (1)
LowProjected EPSHigh
-1.04-1.04-1.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Chembio Diagnostics. Your research has to be compared to or analyzed against Chembio Diagnostics' peers to derive any actionable benefits. When done correctly, Chembio Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Chembio Diagnostics.

Currently Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested over 90 shares
Software
Invested few shares
Continue to Macroaxis Advice on Chembio Diagnostics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
The data published in Chembio Diagnostics' official financial statements usually reflect Chembio Diagnostics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Chembio Diagnostics. For example, before you start analyzing numbers published by Chembio accountants, it's critical to develop an understanding of what Chembio Diagnostics' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Chembio Diagnostics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chembio Diagnostics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Chembio Diagnostics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Chembio Diagnostics. Please utilize our Beneish M Score to check the likelihood of Chembio Diagnostics' management to manipulate its earnings.